BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Chronic hepatitis c
1
Metabolomics in chronic hepatitis C: Decoding fibrosis grading and underlying pathways
11/24/2023 6:10:12 AM | Browse: 215 | Download: 938
2
Acute-on-chronic liver failure induced by antiviral therapy for chronic hepatitis C: A case report
10/25/2023 8:49:11 AM | Browse: 275 | Download: 833
3
Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis C patients
6/9/2022 7:17:55 AM | Browse: 519 | Download: 1948
4
Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil
1/21/2022 8:16:14 AM | Browse: 591 | Download: 1369
5
Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study
11/10/2021 7:13:09 AM | Browse: 753 | Download: 1273
6
Platelet count as a screening tool for compensated cirrhosis in chronic viral hepatitis
5/14/2021 10:27:31 AM | Browse: 668 | Download: 1537
7
Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study
5/10/2021 7:46:10 AM | Browse: 492 | Download: 1497
8
Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond
4/29/2021 2:12:02 AM | Browse: 550 | Download: 1355
9
Production and activity of metalloproteinases during liver fibrosis progression of chronic hepatitis C patients
2/25/2021 3:45:30 PM | Browse: 851 | Download: 1992
10
Management of hepatitis C in children and adolescents during COVID-19 pandemic
8/25/2020 9:16:00 AM | Browse: 793 | Download: 1605
11
Liver-related effects of chronic hepatitis C antiviral treatment
6/14/2020 1:45:26 PM | Browse: 991 | Download: 1843
12
Interleukin-6-174G/C polymorphism is associated with a decreased risk of type 2 diabetes in patients with chronic hepatitis C virus
4/23/2020 10:34:55 AM | Browse: 679 | Download: 2077
13
Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C
1/13/2020 11:27:12 AM | Browse: 1222 | Download: 1782
14
Effects of dual sofosbuvir/daclatasvir therapy on, chronic hepatitis C infected, survivors of childhood malignancy
8/26/2019 2:56:47 AM | Browse: 875 | Download: 2503
15
High prevalence of occult hepatitis C infection in predialysis patients
1/27/2019 7:04:05 AM | Browse: 945 | Download: 1912
16
Challenge to overcome: Nonstructural protein 5A-P32 deletion in direct-acting antiviral-based therapy for hepatitis C virus
10/12/2018 5:32:21 AM | Browse: 824 | Download: 1391
17
Daclatasvir plus asunaprevir in treatment-naïve patients with hepatitis C virus genotype 1b infection
3/26/2018 8:48:04 AM | Browse: 1354 | Download: 2910
18
Proton nuclear magnetic resonance-based metabonomic models for non-invasive diagnosis of liver fibrosis in chronic hepatitis C: Optimizing the classification of intermediate fibrosis
1/26/2018 8:09:36 AM | Browse: 1190 | Download: 1946
19
Efficacy and safety of sofosbuvir and ledipasvir in japanese patients aged 75 years or over with hepatitis C genotype 1
12/27/2017 10:31:19 AM | Browse: 1214 | Download: 2330
20
Hepatitis C virus NS5A region mutation in chronic hepatitis C genotype 1 patients who are non-responders to two or more treatments and its relationship with response to a new treatment
7/7/2017 11:41:16 AM | Browse: 1121 | Download: 2397
21
Interferon related pericarditis: Review
6/26/2017 12:49:43 AM | Browse: 1174 | Download: 1633
22
Efficacy and safety of combined directly acting antivirals for treatment of Chinese chronic hepatitis C patients in a real-world setting
6/14/2017 9:25:57 AM | Browse: 1164 | Download: 2407
23
Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C
6/7/2017 7:22:42 AM | Browse: 1923 | Download: 3735
24
Inducible protein-10 as a predictive marker of antiviral hepatitis C treatment: A systematic review
5/17/2017 6:29:40 AM | Browse: 1457 | Download: 2414
25
Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C genotype 1b
4/6/2017 6:30:00 PM | Browse: 1278 | Download: 1992
26
Fibrosis assessment using FibroMeter combined to first generation tests in hepatitis C
2/27/2017 8:50:00 AM | Browse: 1261 | Download: 1956
27
Influence of vitamin D on liver fibrosis in chronic hepatitis C: A systematic review and meta-analysis of the pooled clinical trials data
2/17/2017 8:32:00 AM | Browse: 1247 | Download: 1914
28
Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C
11/26/2016 6:56:00 PM | Browse: 1246 | Download: 2749
29
Collision tumor of hepatocellular carcinoma and neuroendocrine carcinoma involving the liver: Case report and review of the literature
11/6/2016 3:43:00 PM | Browse: 1013 | Download: 1652
30
Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy
10/14/2016 1:37:00 PM | Browse: 1296 | Download: 1656
31
Impact of hepatitis C virus core mutations on the response to interferon-based treatment in chronic hepatitis C
9/30/2016 5:59:00 PM | Browse: 1274 | Download: 2604
32
Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication
9/4/2016 2:49:00 PM | Browse: 1453 | Download: 2231
33
Hepatitis C virus G1b infection decreases the number of small low-density lipoprotein particles
7/29/2016 8:32:00 PM | Browse: 1205 | Download: 2007
34
Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: Does etiology matter?
4/19/2016 9:45:00 AM | Browse: 1305 | Download: 2976
35
Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1
3/23/2016 4:26:00 PM | Browse: 1441 | Download: 2523
36
Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage
1/20/2016 5:04:00 PM | Browse: 1363 | Download: 1745
37
Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus -infected liver
12/10/2015 10:35:00 AM | Browse: 1216 | Download: 1654
38
Comparison of peg-interferon, ribavirin plus telaprevir vs simeprevir by propensity score matching
12/4/2015 3:24:00 PM | Browse: 1255 | Download: 2692
39
Treatment of chronic hepatitis C in patients with HIV/HCV coinfection
12/2/2015 12:06:00 PM | Browse: 615 | Download: 1202
40
Importance of virological response in the early stage of telaprevir-based triple therapy for hepatitis C
11/18/2015 11:12:00 AM | Browse: 1135 | Download: 1517
41
Factors associated with the response to interferon-based antiviral therapies for chronic hepatitis C
11/18/2015 11:12:00 AM | Browse: 1173 | Download: 2083
42
Era of direct acting antivirals in chronic hepatitis C: Who will benefit?
10/30/2015 11:57:00 AM | Browse: 1579 | Download: 2008
43
Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antivirals
10/14/2015 12:06:00 PM | Browse: 1278 | Download: 1881
44
Hepatitis C virus infection and prisoners: Epidemiology, outcome and treatment
9/23/2015 12:28:00 PM | Browse: 1880 | Download: 2230
45
Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients
8/8/2015 3:25:00 PM | Browse: 1199 | Download: 2621
46
Boceprevir early-access for advanced-fibrosis/cirrhosis in Asia-pacific hepatitis C virus genotype 1 non-responders/relapsers
7/30/2015 11:19:00 AM | Browse: 1359 | Download: 1920
47
Severe immune thrombocytopenia after peg-interferon-alpha2a, ribavirin and telaprevir treatment completion: a case report and systematic review of literature
6/29/2015 5:40:00 PM | Browse: 1146 | Download: 1904
48
Impact of direct acting antiviral-based triple therapy on the serum alpha-fetoprotein level
4/30/2015 2:11:00 PM | Browse: 1132 | Download: 2074
49
Management of hepatitis C infection before and after liver transplantation
4/30/2015 2:11:00 PM | Browse: 1195 | Download: 1824
50
Insulin-like growth factor-1 mRNA isoforms and insulin-like growth factor-1 receptor mRNA expression in chronic hepatitis C
4/7/2015 6:08:00 PM | Browse: 1109 | Download: 2044